Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry

Diabetes Care

Volumn 37, Issue 10, 2014, Pages 2702-2709

  Wong, Jenise C ^a   Foster, Nicole C ^b   Maahs, David M ^c   Raghinaru, Dan ^b   Bergenstal, Richard M ^d   Ahmann, Andrew J ^e   Peters, Anne L ^f   Bode, Bruce W ^g   Aleppo, Grazia ^h   Hirsch, Irl B ⁱ   Kleis, Lora ^j   Chase, H Peter ^c   DuBose, Stephanie N ^b   Miller, Kellee M ^b   Beck, Roy W ^b   Adi, Saleh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d INTERNATIONAL DIABETES CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g ATLANTA DIABETES ASSOCIATES   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j HELEN DEVOS CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CHILD; COHORT ANALYSIS; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING DEVICE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE REGISTRY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; GLUCOSE ASSAY; HOUSEHOLD; HUMAN; HYPOGLYCEMIA; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; OUTCOME ASSESSMENT; PRIVATE HEALTH INSURANCE; SEVERE HYPOGLYCEMIA; YOUNG ADULT; AMBULATORY MONITORING; BLOOD; BLOOD GLUCOSE MONITORING; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL; INCIDENCE; INSULIN INFUSION; METABOLISM; PATIENT EDUCATION; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; UTILIZATION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INCIDENCE; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY; PATIENT EDUCATION AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84908164031     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0303     Document Type: Article

References (18)

1. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
2. Beck RW, Hirsch IB, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
3. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
4. Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012;1:CD008101.
5. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805.
6. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes.NEngl JMed 2008;359:1464-1476.
7. Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta analysis. Ann Intern Med 2012;157:336-347.
8. Beck RW, Buckingham B, Miller K, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
9. Klonoff DC, Buckingham B, Christiansen JS, et al.; Endocrine Society. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96: 2968-2979.
10. Mauras N, Fox L, Englert K, Beck RW. Continuous glucose monitoring in type 1 diabetes. Endocrine 2013;43:41-50.
11. Phillip M, Danne T, Shalitin S, et al.; Consensus Forum Participants. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012;13:215-228.
12. Mauras N, Beck R, Xing D, et al.; Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to, 10 years. Diabetes Care 2012;35:204-210.
13. Beck RW, Lawrence JM, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010;33:2175-2177.
14. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network. The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389.
15. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005;28:1231-1239.
16. National Government Services. Glucose Monitors: Policy Article: July 1, 2011. Centers for Medicare and Medicaid Services, Baltimore, MD, 2011.
17. Bartelme A, Bridger P. The role of reimbursement in the adoption of continuous glucose monitors. J Diabetes Sci Tech 2009;3:992-995.
18. American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care 2014;37(Suppl. 1):S14-S80.